Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ProQR Therapeutics N.V (PRQR) Treasury Shares: 2021-2025

Historic Treasury Shares for ProQR Therapeutics N.V (PRQR) over the last 5 years, with Sep 2025 value amounting to $2.8 billion.

  • ProQR Therapeutics N.V's Treasury Shares rose 98121.09% to $2.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 billion, marking a year-over-year increase of 98121.09%. This contributed to the annual value of $2.7 billion for FY2024, which is 85188.82% up from last year.
  • Per ProQR Therapeutics N.V's latest filing, its Treasury Shares stood at $2.8 billion for Q3 2025, which was up 103,127.36% from $2.7 million recorded in Q2 2025.
  • In the past 5 years, ProQR Therapeutics N.V's Treasury Shares ranged from a high of $2.8 billion in Q3 2025 and a low of $2.5 million during Q1 2025.
  • For the 3-year period, ProQR Therapeutics N.V's Treasury Shares averaged around $496.6 million, with its median value being $3.1 million (2023).
  • In the last 5 years, ProQR Therapeutics N.V's Treasury Shares dropped by 23.24% in 2024 and then skyrocketed by 98,121.09% in 2025.
  • Quarterly analysis of 5 years shows ProQR Therapeutics N.V's Treasury Shares stood at $4.1 million in 2021, then decreased by 14.43% to $3.5 million in 2022, then dropped by 11.02% to $3.1 million in 2023, then skyrocketed by 85,646.82% to $2.7 billion in 2024, then skyrocketed by 98,121.09% to $2.8 billion in 2025.
  • Its Treasury Shares stands at $2.8 billion for Q3 2025, versus $2.7 million for Q2 2025 and $2.5 million for Q1 2025.